Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
39.59
+0.18 (0.44%)
At close: Dec 4, 2025, 4:00 PM EST
39.62
0.00 (0.00%)
Pre-market: Dec 5, 2025, 6:03 AM EST
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $1.16 billion as of December 5, 2025. Its market cap has increased by 48.00% in one year.
Market Cap
1.16B
Enterprise Value
906.05M
1-Year Change
48.00%
Ranking
Category
Stock Price
$39.59
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $1.16B, an increase of 839.82%. That is a compound annual growth rate of 42.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.16B | 54.94% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | 1.62B | 176.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |